Chlamydiae are obligate intracellular bacteria that are dependent on eukaryotic host cells for ribonucleoside triphosphates. The purpose of the present study was to determine whether Chlamydia trachomatis obtains deoxyribonucleotides from the host cell. The study was aided by the finding that host and parasite DNA synthesis activity could be distinguished by their differing sensitivities to aphidicolin and norfloxacin. Results from isotope incorporation experiments indicated that any nucleobase or ribonucleoside that could serve as a precursor for host DNA synthesis could also be utilized by C. trachomatis for DNA replication. C. trachomatis utilized only those precursors which the host cell converted to the nucleotide level. Pyrimidine deoxyribonucleosides were efficient precursors for host DNA synthesis; however, they were not used by C. trachomatis. On the other hand, purine deoxyribonucleosides appeared to be efficient precursors for both host cell and parasite DNA. Since purine deoxyribonucleosides are rapidly catabolized by host cells, it is necessary to regulate their metabolism to determine whether they serve as direct precursors for C. trachomatis DNA synthesis. This was partially achieved by using a hypoxanthine-guanine phosphoribosyltransferase-negative cell line and using deoxycoformycin and 8-aminoguanosine as inhibitors of (deoxy)adenosine deaminase and purine nucleoside phosphorylase, respectively. The results indicated that purine deoxyribonucleosides are efficiently utilized for host cell DNA synthesis even if degradation pathways are inhibited and salvage to ribonucleotides is minimized. In sharp contrast, the purine deoxyribonucleosides were utilized by C. trachomatis as precursors for DNA synthesis only when host catabolic pathways and salvage reactions were intact. High-pressure liquid chromatographic analysis of nucleotide pools extracted from host cells pulsed with radiolabeled precursors suggests that infected cells transport and phosphorylate all deoxynucleosides as effectively as mock-infected control cultures. In aggregate, these results show that chlamydiae do not take up deoxyribonucleotides from the host cells.
sponsible for a wide range of infections including trachoma, lymphogranuloma venereum, and reproductive tract infections (8, 21) . Despite the clinical importance of C. trachomatis, only limited data are available concerning its biochemistry (for reviews, see references 17, 21, and 22) . The essential survival strategy employed by chlamydiae is intracellular parasitism. The pathogen displays a unique developmental cycle consisting of an extracellular infectious elementary body and an intracellular noninfectious reticulate body.
The metabolic capabilities of chlamydiae are limited. The specific host-supplied factors which permit chlamydiae to grow are not known. Chlamydiae appear to rely on their hosts for a wide variety of nutrients, including many precursors (amino acids and nucleotides) of macromolecules which other bacteria normally synthesize (17, 21, 22) . In adapting to intracellular life, chlamydiae appear to have lost whatever energy-producing systems they might once have had (17, 21, 22) . As such, chlamydiae apparently lack the ability to generate net ATP and are speculated to be energy parasites depending solely on the host cells they parasitize for highenergy intermediates required for the biosynthesis of macromolecules (17, 21, 22) . The work of Hatch (9) has conclusively shown that C. psittaci can draw on the total acid-soluble ribonucleoside triphosphate (NTP) pools of its host for biosynthesis of its own RNA.
The mechanism by which chlamydiae obtain deoxyribo-* Corresponding author.
nucleoside triphosphate (dNTP) precursors for DNA synthesis has not yet been established. The unimpaired synthesis of chlamydial DNA in cycloheximide-inhibited host cells suggests that replication of host DNA is not required for biosynthesis of parasite DNA (16) . In support of this, Alexander (1) found that chlamydiae make DNA at the same rate in either multiplying or nonmultiplying host cells. In addition, chlamydiae are capable of efficient infection and replication in stationary-phase cells (17, 21, 22) , when concentrations of dNTPs are extremely low (23) . The pioneering work of Tribby and Moulder (24) done in the mid-1960s indicated that in mouse L cells, C. psittaci readily incorporates most exogenously supplied nucleosides and nucleobases into host cell and C. psittaci DNA and RNA. Interestingly, they reported that purine deoxyribonucleosides were incorporated into chlamydial DNA but that pyrimidine deoxyribonucleosides were incorporated into DNA poorly or not at all. The nonincorporation of thymidine has been the most thoroughly documented (3, 10, 14) . Even when the host cell has a fully active thymidine kinase and there is extensive labeling of host cell DNA, thymidine is minimally incorporated into chlamydial DNA (3, 10) . Furthermore, C. psittaci lacks detectable thymidine kinase and grows normally in thymidine kinase-deficient L cells (10) . These findings have led to the hypothesis that C. psittaci is unable to transport thymidine nucleotides from the host cell and imply that the parasite is capable of synthesizing its own TTP. The current study was undertaken not only to clarify the inconsistencies in the existing literature but also to positively identify the source of deoxyribonucleotides required for C. trachomatis DNA synthesis. Our results indicate that C. trachomatis does not draw on host cell dNTP pools as a source of deoxyribonucleotides. These findings lead us to propose that chlamydiae obtain precursors for DNA synthesis from the host cell as ribonucleotides and that they likely encode a ribonucleotide reductase for the synthesis of deoxyribonucleotides.
MATERIALS AND METHODS Materials. [2-3H] adenine (28 Ci/mmol), [2,8-3H] adenosine (38 Ci/mmol), [2,8-3H] deoxyadenosine (36 Ci/mmol), [8-'4C] guanine (56 mCi/mmol), [8-3H] guanosine (7 Ci/mmol), [8-3H] deoxyguanosine (7 Ci/mmol), [2-3H] hypoxanthine (25 Ci/ mmol), [5-3H] uridine (20 Ci/mmol), [6_3H] deoxyuridine (20 Ci/mmol), [methyl-3H]thymidine (37 Ci/mmol), and [6-3H] uracil (30 Ci/mmol) were purchased from Moravek Biochemicals, Inc. Aphidicolin, norfloxacin, cycloheximide, and 8-aminoguanosine (8-AG) were obtained from Sigma. Deoxycoformycin (dCF) was a gift from J. Johnston, Manitoba Institute of Cell Biology, Winnipeg.
Cell lines and culture conditions. The cell lines described in this study were routinely cultured at 37°C on the surface of plastic tissue culture flasks (Corning Glass Works) in a-minimal essential medium (GIBCO) supplemented with 10% fetal calf serum (GIBCO). The mouse L-cell line was kindly provided by J. Wright, Manitoba Institute of Cell Biology, Winnipeg. The wild-type CHO cell line and the hypoxanthineguanine phosphoribosyltransferase-negative (HGPRT-) CHO cell line were obtained from J. Hamerton, Department of Human Genetics, University of Manitoba, Winnipeg. For logarithmically growing cultures, approximately 105 cells were plated onto 5-cm dishes and grown for 36 to 40 h at 37°C in 5 ml of a-minimal essential medium-10% fetal calf serum-to a density of approximately 106 cells.
Chlamydial propagation. C. trachomatis L2/434/Bu, obtained from R. Brunham, Department of Medical Microbiology, University of Manitoba, Winnipeg, was used throughout this study. Confluent monolayers (3 x 106 to 4 x 106 cells per 5-cm plate) of wild-type mouse L cells, wild-type CHO cells, and mutant HGPRT-CHO cells were infected at a multiplicity of infection (MOI) of 3 to 5 infection-forming units per cell, which resulted in 90 to 100% infection with little host cell toxicity. C. trachomatis was grown as previously described (19) , and unless otherwise indicated, 1 ,ug of cycloheximide per ml was present in the postinfection growth medium. Mock-infected (MI) host cell cultures were treated in the same fashion as infected cultures except that C. trachomatis was not added. Cycloheximide (1 ,ug/ml) was always present in MI cell culture medium.
Incorporation of radiolabeled nucleobases, nucleosides, and deoxynucleosides into host cell and C. trachomatis DNA. Radiolabeling experiments were done as described by Nicander and Reichard (18) . Briefly, isotope experiments were performed with parallel dishes (5-cm dishes, 5 ml of medium) of logarithmically growing (1.0 x 106 cells per plate) and stationary-phase (3 x 106 to 4 x 106 cells per plate in the presence of 1 ,ug of cycloheximide per ml) cultures mock infected or infected with C. trachomatis (3 x 106 to 4 x 106 cells per plate in the presence of 1 ,ug of cycloheximide per ml). Three hours before the addition of isotope or inhibitors, the medium volume was reduced to 2.0 ml and buffered with 1 M HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.4; final concentration, 20 mM). For C. trachomatis-infected cultures, medium volume was reduced at 19 h postinfection and radiolabel was added at 22 h postinfection, a time when L2 DNA synthesis is at a maximum. A 3H-labeled nucleobase, nucleoside, or deoxynucleoside was added without dilution directly to the medium to achieve a final concentration of 0. 3 ,uM. ["4C]guanine was also added to achieve a final concentration of 0.3 ,uM (0.5 ,uCi/ml). Incubation in the presence of isotope was continued for 3 h. In all cases, incorporation of label into DNA remained linear beyond 3 h and at no time was isotope limiting in the experiments. When required, inhibitors (aphidicolin, norfloxacin, dCF, or 8-AG) were added 2 h before the addition of isotope.
To terminate incubations, the dishes were transferred immediately to an ice bath, medium was sucked off, and the cells were washed rapidly (three times) with 5 ml of ice-cold Tris-buffered saline (pH 7.4) and placed for 1 min in a vertical position on ice before the remaining buffer was removed. When necessary, nucleotides were extracted with 1.5 ml of 60%o methanol for 2 h at -20°C. The methanolic solution was removed from the plate and saved for analysis of deoxyribonucleotides. The cells remaining on the dish were dissolved in 0.3 M NaOH and then incubated for 16 h at 37°C to degrade RNA. DNA was precipitated by the addition of 10 ml of 10% trichloroacetic acid containing 0.1 M sodium PPi. The precipitate was collected on Whatman GF/B glass microfiber filters, and after being washed with 10% trichloroacetic acid-0.1 M sodium PP1 and ethanol, the dried filters were counted in a liquid scintillation counter (Beckman LS 5000). Methanol extracts were evaporated to dryness in a Savant Speed-Vac evaporator, and the residue was redissolved in 0.1 ml of 10 mM Tris-HCl buffer (pH 7.4). Isotope incorporation into dNMP, dNDP, and dNTP was measured by on-line radioactive flow detection (Beckman 171 detector) after separation of the deoxynucleotides by high-pressure liquid chromatography (HPLC) on a 12.5-cm Partisphere C18 column (Whatman), using buffer a (doubledistilled H20) and buffer b (0.15 M NaCl, 25 mM tetrabutylammonium dihydrogen [pH 6 .0], 5% methanol). For separation of pyrimidine deoxynucleotides (dC, dT), the column ran isocratically for 3.0 min at 1.0 ml/min with 50% buffer b. From 3.0 to 4.0 min, a linear gradient changed the buffer from 50% buffer a and 50% buffer b to 100% buffer b. Buffer b then ran isocratically from 4 to 20 min. For separation of purine deoxynucleotides (dA, dG), the column ran isocratically from 2.5 to 20 min. The identity of the radioactive peaks was confirmed by simultaneously monitoring the A254 of known dNMP, dNDP, and dNTP standards. All analyses were made on duplicate dishes, with results varying by less than 10%. Unless otherwise indicated, all results are normalized to 106 cells. For C. trachomatis-infected cultures, percent infection was monitored by light microscopy and experiments were not performed unless 90 to 100% of the cells were infected. Under these circumstances, 106 cells is taken to mean approximately 106 infected cells.
RESULTS
Effect of aphidicolin and norfloxacin on mouse L-cell and C. trachomatis DNA synthesis. One of the difficulties encountered when studying in situ metabolic activities of intracellular parasites is the need for a procedure which allows for a distinction between host and parasite activity. Studies on chlamydia-specific protein synthesis have been aided by the use of two antibiotics, chloramphenicol and cycloheximide, which selectively inhibit prokaryotic and eukaryotic protein synthesis activity, respectively (1, 2 Fig. 1 . The results indicated that aphidicolin is a very potent inhibitor of eukaryotic mouse L-cell DNA synthesis activity, while having little or no effect on C. trachomatis DNA replication (Fig. 1A) . In contrast, norfloxacin inhibited prokaryotic C.
trachomatis DNA synthesis activity, while having a negligible effect on host mouse L-cell activity (Fig. 1B) . Throughout this study, we made use of the selectivity of these two inhibitors to aid in the differentiation of host-from parasitespecific DNA synthesis.
Over the years, conflicting evidence has been reported with regard to the effect of chlamydial infection on the synthesis of host cell DNA (17, 21, 22 ). It appears that most of the discrepencies result from differences in the initial MOI used in the various studies (3 Table 2 . Three (adenine, guanine, hypoxanthine) of the four nucleobases tried were efficiently used as DNA precursors; again, the exception was uracil. The detected DNA synthesis activity was inhibited by norfloxacin but unaffected by aphidicolin, a result indicating that the observed activity is parasite specific. All four ribonucleosides (adenosine, guanosine, cytidine, uridine) tested were good precursors for parasite-specific DNA replication. In addition, the purine deoxynucleosides (dA and dG) were utilized effectively by C. trachomatis. In sharp contrast, the results of labeling experiments utilizing the three pyrimidine deoxynucleosides (dC, dU, and dT) showed very low levels of incorporation. The small amount of activity demonstrated was sensitive to aphidicolin and resistant to norfloxacin. These results indicate that the observed DNA synthesis activity was host specific.
Incorporation of purine deoxynucleosides into DNA of C. trachomatis growing in wild-type and HGPRT-Chinese hamster ovary cells. The results presented above suggested that purine deoxynucleosides (dA and dG) are effective precursors for C. trachomatis DNA synthesis but that pyrimidine deoxynucleosides (dC, dU, dT) are utilized by the parasite very poorly or not at all. More than pyrimidine deoxynucleosides, purine deoxynucleosides are highly susceptible to degradative deamination and/or phosphorylysis in most mammalian cells (15) . The major pathways involved in deoxyadenosine and deoxyguanosine metabolism in mammalian cells are outlined in Fig. 2A and B, respectively. When doing labeling experiments with purine deoxynucleosides, we consistently noted extensive incorporation of radiolabel into host and C. trachomatis RNA as well as DNA (data not shown). These results strongly suggested that degradative pathways of purine deoxynucleoside metabolism were being utilized. This complication makes it difficult to distinguish whether C. trachomatis is actually taking up dATP and dGTP directly from the host or whether radiolabeled ATP and GTP are being transported with subsequent chlamydia-directed conversion to deoxynucleotides before polymerization into DNA.
To differentiate between these two possibilities, we designed a strategy which would substantially reduce the amount of purine deoxynucleosides that were degraded and salvaged as ribonucleotides and, as a result, would favor the direct phosphorylation of the added deoxynucleosides. This strategy required the use of a mutant cell line and two specific inhibitors of deoxynucleoside degradation. The mutant was an HGPRT-Chinese hamster ovary (CHO) cell line. As a result of the HGPRT-phenotype, these cells can no longer efficiently salvage hypoxanthine or guanine ( Fig.  2A and B, step 3) .
As a first step in these studies, it was necessary to determine whether C. trachomatis could grow in wild-type and HGPRT-CHO cells. C. trachomatis replication in these two cell lines was monitored by titrating the number of infectious elementary bodies formed at the end of a growth cycle (48 h postinfection) by the inclusion counting method. We found that C. trachomatis grew as well in the CHO cell lines as it did in mouse L cells (data not shown). In addition, an identical pattern of nucleotide precursor utilization was found for C. trachomatis growing in wild-type CHO cells as was reported in Table 2 presence of 1 ,ug of cycloheximide per ml to utilize several different bases, ribonucleosides, and deoxynucleosides as precursors for DNA replication is shown in Table 3 . Logarithmically growing HGPRT-cell DNA was readily labeled when adenine, cytidine, or thymidine was used as a nucleic acid precursor. In keeping with the HGPRTphenotype, there was very little labeling of DNA when hypoxanthine, guanosine, or deoxyguanosine was supplied as the precursor and poor incorporation of medium-supplied adenosine and deoxyadenosine. The inefficient utilization of guanosine, deoxyguanosine, adenosine, and deoxyadenosine suggests that the majority of these precursors are channeled through the catabolic pathway rather than being directly phosphorylated to their corresponding (deoxy)ribonucleotide. As expected, the MI HGPRT-cells showed the same pattern of precursor utilization as did logarithmically growing HGPRT-cells; however, the total incorporation was much reduced as a result of the culture conditions (confluent cells plus cycloheximide) (Table 3) . Of all the precursors tested, only adenine and cytidine were efficiently used for labeling DNA in C. trachomatis-infected HGPRT-cells in the presence of cycloheximide. The inability of C. trachomatis to utilize thymidine when growing in the HGPRTcells is in keeping with our earlier findings in mouse L cells. Adenosine was utilized to some extent as a precursor for labeling DNA in infected HGPRT-cells; however, the other three purine (deoxy)ribonucleosides and hypoxanthine were essentially not used by the parasite.
It has been shown in both mouse and human cell lines that one of the consequences of an HGPRT-phenotype is increased excretion of purines (hypoxanthine, xanthine, guanine) into the culture medium by mutant cells when compared with their wild-type parent strain (6, 11, 25) . These results have led to the suggestion that even in the absence of HGPRT-, the majority of the intracellular purine (deoxy)ribonucleosides are processed by degradative pathways ( Fig. 2A and B) ; however, since the mutant cells cannot salvage the free bases, they are excreted by the cells.
To reduce the competition between the degradation and kinase pathways for the purine deoxynucleoside precursors, we used two nucleoside analog inhibitors. dCF (5) and 8-AG (12) are specific inhibitors of the two main purine nucleoside catabolic pathway enzymes, (deoxy)adenosine deaminase and purine nucleoside phosphorylase, respectively (Fig. 2) . In the presence of dCF and/or 8-AG, less purine deoxynucleoside is degraded, and as a result, more substrate is available for the deoxynucleoside kinase reactions. 
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The results of purine deoxynucleoside incorporation studies with logarithmically growing MI and C. trachomatisinfected wild-type and HGPRT-cells in the presence and absence of dCF and 8-AG are shown in Table 4 . Once again, aphidicolin and norfloxacin were used to distinguish host cell from parasite DNA synthesis activity. Also shown in Table  4 When wild-type CHO cells were infected with C. trachomatis, there was efficient incorporation of both dA and dG into DNA. The activity was parasite specific, as indicated by decreased incorporation in the presence of norfloxacin and essentially no change in the presence of aphidicolin. The addition of 8-AG and/or dCF to infected wild-type cells caused a decrease in the level of incorporation of both labeled dA and dG. Under these conditions, the measured activity was inhibited by both aphidicolin and norfloxacin. These results indicate that both host and parasite DNA synthesis activities were contributing to the total incorporation.
When HGPRT-cells were infected with C. trachomatis, there was no significant incorporation of medium-supplied dA or dG into DNA (Table 4 ). When C. trachomatis-infected HGPRT-cells were labeled with dA in the presence of dCF and 8-AG, there was significant incorporation of radiolabel into DNA, although not much more than MI control cultures. The measured DNA synthesis activity was inhibited by aphidicolin and by norfloxacin to some extent. When infected HGPRT-cells were labeled with dG in the presence of 8-AG, the total incorporation of label into DNA was low. The DNA synthesis activity detected was inhibited by aphidicolin and not affected by norfloxacin.
Also shown in Table 4 is the calculated ratio of the total number of counts incorporated into DNA with cytidine, dA, and dG in the absence of dCF and/or 8-AG, divided by the total incorporation into DNA with each precursor in the presence of dCF and/or 8-AG. The significance of these ratios will be addressed in the Discussion.
Composition of deoxynucleotide precursor pools in MI and C. trachomatis-infected mouse L cells. The possibility exists that there is a difference in the proportion of the transported deoxynucleoside precursor that is phosphorylated to the triphosphate level by a C. trachomatis-infected cell compared with an uninfected control culture. If this is the case, it may be argued that C. trachomatis does not incorporate a significant amount of any deoxynucleoside precursor be- cause the infected host cell does not raise the deoxynucleoside to the deoxynucleotide triphosphate. This question was directly addressed by comparing the deoxynucleotide precursor pools in MI mouse L cells with those in C. trachomatis-infected mouse L cells. Cells were labeled for 3 h with one of the four deoxyribonucleosides (0.3 ,iM) as was done for the DNA incorporation studies. At the end of the labeling period, the soluble nucleotide pools were extracted from the cells with 60% methanol (see Materials and Methods for details), and the total amount of radiolabel present in the soluble nucleotide pool was determined. In addition, the composition of the total pool was analyzed by HPLC and the proportion of the pool that was present as mono-, di-, and triphosphate nucleotide derivatives was calculated. The results of these experiments are shown in Table 5 . The labeling experiments with deoxyadenosine and deoxyguanosine were done in the presence or absence of dCF and 8-AG. In both MI and infected cultures, the presence of dCF and/or 8-AG dramatically reduced the total amount of radiolabel present in the soluble nucleotide pool but did not significantly affect the distribution of the label between mono-, di-, and triphosphate nucleotide derivatives. The reduction in total incorporation likely resulted from blocking of the purine deoxynucleoside degradation pathway. In support of this hypothesis, we found that the majority (>80%) of the soluble nucleotide pool present in MI and infected cells after labeling with dA or dG in the absence of dCF and/or 8-AG was ribonucleotide derivatives and not deoxynucleotides (data not shown). In contrast, in the presence of dCF and/or 8-AG, the proportion of the total soluble pool that was represented by ribonucleotides was greatly reduced (data not shown). No trend was observed when the total amount of radioactivity recovered in an individual nucleotide pool from MI cells was compared with the amount recovered from C. trachomatis-infected cultures. For example, with deoxyadenosine, less radioactivity was recovered from infected cultures than from MI cultures; however, with thymidine, the reverse result was obtained. More important, there was no significant difference in the proportional distribution of label among deoxynucleoside mono-, di-, and triphosphates when C. trachomatis-infected cultures were compared with MI control cultures. DISCUSSION We are particularly interested in determining the process by which C. trachomatis obtains dNTPs as substrates for DNA polymerase. A major obstacle encountered when studying chlamydial DNA synthesis in situ is that it can be difficult to distinguish host-from parasite-specific activity. This is especially true when experiments are conducted in the absence of cycloheximide. Our studies on C. trachomatis DNA synthesis were aided by the discovery that we could differentially inhibit host and parasite DNA replication with aphidicolin and norfloxacin, respectively (Fig. 1) . By taking advantage of the specificity of aphidicolin and norfloxacin, we were able to show conclusively that both host and parasite are actively synthesizing DNA in C. trachomatisinfected logarithmically growing mouse L cells (Table 2) . dNTPs can be formed by de novo synthesis from small molecules or by salvage pathways. Salvage can involve direct phosphorylation of deoxynucleosides or direct phosphorylation of ribonucleosides and then reduction of the ribose moiety (20) . The proper balance between dNTP pools is maintained by a network of biosynthetic and catabolic reactions. Especially important is the complicated allosteric control regulating the activity and/or specificity of key enzymes of both de novo and salvage pathways (20) . The enzyme ribonucleotide reductase occupies a central position in the synthesis of dNTPs, since it is the only enzyme which catalyzes the de novo synthesis of dNTPs from NTPs (13, 20) .
Given that chlamydiae do not synthesize purine and pyrimidine nucleotides de novo and lack deoxynucleoside kinases, three alternatives appear available to the parasite for obtaining dNTPs. One is that dNTPs could be obtained directly from the host cell in a manner similar to that used for ribonucleotides. Second, NTPs could be obtained from the host with subsequent conversion to dNTPs by a chlamydiaspecific ribonucleotide reductase enzyme. The third possibility is that chlamydiae are flexible and both processes occur. The results presented in this study support the hypothesis that C. trachomatis likely obtains dNTPs exclusively by way of the second alternative. Our results indicate that all nucleobases and ribonucleosides that were utilized by the host cell as precursors for DNA synthesis could also be utilized by C. trachomatis (Table 2) . These results are in agreement with those reported for C. psittaci (24) . The only nucleobase that was not used by C. trachomatis was uracil, and it was also not utilized by the host mouse L cell. In keeping with its phenotype, the HGPRT-CHO cell line did not efficiently use adenosine, deoxyadenosine, guanosine, deoxyguanosine, or hypoxanthine as a precursor for DNA synthesis (Table 3) . Interestingly, C. trachomatis also did not use any of the above precursors when growing in HGPRT-cells. These findings support the hypothesis that chlamydiae can utilize medium-supplied nucleic acid precursors only if the host cell is capable of elevating them to the nucleotide level (4, 17 (23) , the nonutilization of thymidine by chlamydiae is unlikely to be related to the absolute size of the TTP pool present in the host cell.
Even though deoxycytidine and deoxyuridine were efficient precursors for host DNA synthesis, they were not utilized by C. trachomatis (Table 2) . These findings are similar to those reported by Tribby and Moulder (24) for C. psittaci. In addition, HPLC measurement of deoxynucleotide pools clearly indicated that exogenously supplied dC and dT are transported and subsequently phosphorylated to the triphosphate level, presumably by host-specified kinases, in both MI and infected cells (Table 5) . Therefore, the inability of C. trachomatis to incorporate pyrimidine deoxynucleosides into DNA is not a result of the host cell not making the dCTP and TTP available to the parasite. As a result, the most likely explanation for lack of utilization is that chlamydiae do not transport pyrimidine dNTPs.
The evaluation of utilization of purine deoxynucleosides by chlamydiae was more problematic because of the susceptibility of these precursors to degradation in most mammalian cells. To regulate purine deoxyribonucleoside metabolism, we used an HGPRT-cell line and dCF and 8-AG as inhibitors of (deoxy)adenosine deaminase and purine nucleoside phosphorylase, respectively. The complexity of the system sets a limit to the level of our interpretation. However, the results obtained support the hypothesis that C. trachomatis does not draw on host purine dNTP pools as a source of DNA precursors. In contrast, Tribby and Moulder (24) concluded that dA and dG were efficiently utilized by C. psittaci as precursors for DNA synthesis. Examination of their results showed that a large portion of the radiolabeled dA and dG that was supplied was incorporated into RNA (24) . Clearly, these purine precursors followed the catabolic pathways outlined in Fig. 2 and were salvaged as ATP and/or GTP, the precursors for RNA polymerase. We also found that dA and dG were efficiently utilized by C. trachomatis for DNA synthesis (Table 4) . However, when precautions were taken to minimize the catabolic reactions by adding dCF and/or 8-AG and to prevent salvage by using an HGPRT-cell line, the incorporation of dA and dG into parasite DNA was essentially abolished (Table 4 ). We conclude that chlamydiae are unable to directly utilize purine deoxyribonucleotides from the host cell.
The results of experiments supporting this conclusion are presented in Table 4 . A summary of these data is presented as the ratio of counts incorporated into DNA in the absence of dCF and/or 8-AG over the counts incorporated in the presence of the inhibitors (Table 4 , ratio columns). Our control experiments measured cytidine incorporation into DNA by logarithmically growing, MI, and infected wild-type and HGPRT-cells under the two different conditions. Before cytidine nucleotides can be utilized for DNA synthesis, the ribose moiety must be reduced to its deoxy derivative, a reaction catalyzed by ribonucleotide reductase. The cytidine ratio is close to 1 for both wild-type and HGRPTcells whether infected, MI, or logarithmically growing. These results suggest that dCF and/or 8-AG do not significantly alter the specific activity of the dCTP pool or directly affect host or parasite DNA replication. Incorporation ratios above 1 for dA and dG could be interpreted as decreased VOL. 173, 1991 on November 7, 2017 by guest http://jb.asm.org/ Downloaded from DNA synthesis activity in the presence of dCF and/or 8-AG. However, since cytidine incorporation data suggest that these inhibitors do not directly affect DNA synthesis, the decreased incorporation of dA and dG is likely a reflection of a decreased specific activity of the corresponding dNTP pool. Similarly, although ratios below 1 could be interpreted as increased DNA synthesis activity in the presence of dCF and/or 8-AG, they more likely reflect the increased specific activity of the dATP and dGTP pools in the presence of inhibitors. The results obtained are in keeping with our current understanding of the regulation of enzymes involved in (deoxy)nucleoside metabolism in mammalian cells. Calculated ratios were above 1 for logarithmically growing wild-type cells and C. trachomatis-infected wild-type cells. In these two cases, addition of dCF and/or 8-AG likely leads to a decrease in the specific activity of the purine dNTP pools because host cell catabolism and salvage of labeled precursor to ribonucleotides is substantially reduced. For infected cultures at confluence in the presence of cycloheximide, the vast majority of host cells are in a resting state and host cell ribonucleotide reductase levels are extremely low (20; unpublished observations). As a result, the contribution to the dNTP pool from host cell de novo synthesis would be greatly reduced and the specific activity of the purine dNTP pools would increase. Since chlamydiae must draw on host NTP pools as their only source of nucleotides, they will be directly affected by the specific activity of the host ribonucleotide pools. In the presence of dCF and/or 8-AG, the specific activities of the host purine ribonucleotide pools decrease. Taken together, these results suggest that a reduction in the specific activity of C. trachomatis purine dNTP pools would only occur if the parasite has the capacity to convert NTPs to dNTPs and at the same time lacks the ability to transport dNTPs directly from the host.
When HGPRT-cells are labeled with purine deoxynucleosides, very little radiolabel can enter the purine ribonucleotide pool because of the inability of these cells to salvage guanine and hypoxanthine. Therefore, the contribution of radiolabel to the dNTP pool from the salvage pathway via ribonucleotide reductase is negligible. Despite the facts that chlamydiae are rapidly replicating their DNA, as indicated by labeling from cytidine, and that there is high specific activity of the MI host purine dNTP pool in the presence of dCF and/or 8-AG, as indicated by high levels of dA and dG incorporation into host DNA, C. trachomatis-infected HGPRT-cells do not incorporate significantly more dA or dG into DNA than do MI control cultures. These results again suggest that C. trachomatis does not rely on host cell purine dNTP pools as a source of DNA precursors.
In conclusion, the results reported in this study support the hypothesis that C. trachomatis does not draw on host cell dNTP pools as a source of DNA precursors. As an alternative, we propose that C. trachomatis obtains substrates for DNA polymerase from the host cell as ribonucleotides, with subsequent conversion to deoxyribonucleotides being done by a chlamydial-specific ribonucleotide reductase activity. There are two main advantages to this later process of dNTP acquisition. It ensures that chlamydiae will have a supply of dNTPs even in nondividing host cells where concentrations of dNTPs, but not NTPs, could be limiting. Second, by being in control of their dNTP synthesis, chlamydiae can ensure that a balanced supply of dNTPs is generated, which will help preserve the fidelity of DNA replication.
